Literature DB >> 2841377

Changes in outer membrane proteins of nontypable Haemophilus influenzae in patients with chronic obstructive pulmonary disease.

K Groeneveld1, L van Alphen, P P Eijk, H M Jansen, H C Zanen.   

Abstract

Five individual colonies of Haemophilus influenzae were isolated from each of one to three cultures of sputum collected from 18 patients with chronic obstructive pulmonary disease (COPD). The isolates were studied to investigate whether the major outer membrane proteins (MOMPs) changed during persistence. The relationship between isolates was analyzed by fingerprinting their chromosomal DNA. The fingerprints of eight strains (isolated from eight patients) with various MOMP compositions were different, whereas fingerprints of isolates with identical MOMP compositions were indistinguishable. In 12 patients, two or more strains with different MOMP compositions were found; one strain was isolated from the sputum samples of each of the six remaining patients. In seven of the 12 patients, strains with different MOMPs but with indistinguishable fingerprints were found. The differences were found in proteins b,c (five patients) and d (five patients). In patients with COPD, the MOMPs of H. influenzae are subject to changes that may enable this bacterium to escape immunological defense mechanisms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841377     DOI: 10.1093/infdis/158.2.360

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung.

Authors:  D C Webb; A W Cripps
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Variation in metabolic enzyme activity of persistent Haemophilus influenzae in respiratory tracts of patients with cystic fibrosis.

Authors:  L V Möller; H Grasselier; J Dankert; L van Alphen
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

3.  Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease.

Authors:  K Groeneveld; L van Alphen; C Voorter; P P Eijk; H M Jansen; H C Zanen
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

4.  Determination of the epidemiology and transmission of nontypable Haemophilus influenzae in children with otitis media by comparison of total genomic DNA restriction fingerprints.

Authors:  B G Loos; J M Bernstein; D M Dryja; T F Murphy; D P Dickinson
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

Review 5.  Lung infections. 1. Role of bacteria in the pathogenesis and progression of acute and chronic lung infection.

Authors:  R A Stockley
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

6.  Fine mapping of outer membrane protein P2 antigenic sites which vary during persistent infection by Haemophilus influenzae.

Authors:  B Duim; L Vogel; W Puijk; H M Jansen; R H Meloen; J Dankert; L van Alphen
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 7.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

8.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.

Authors:  I S Patel; T A R Seemungal; M Wilks; S J Lloyd-Owen; G C Donaldson; J A Wedzicha
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

9.  Immune selection for antigenic drift of major outer membrane protein P2 of Haemophilus influenzae during persistence in subcutaneous tissue cages in rabbits.

Authors:  L Vogel; B Duim; F Geluk; P Eijk; H Jansen; J Dankert; L vanAlphen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Antigenic variation of immunoglobulin A1 proteases among sequential isolates of Haemophilus influenzae from healthy children and patients with chronic obstructive pulmonary disease.

Authors:  H Lomholt; L van Alphen; M Kilian
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.